GET DAILY SIGNALSFXG vs PBJ: Two Different Paths to Consumer Staples Exposure
Key Takeaways
- Both FXG and PBJ are smart-beta, rules-based ETFs focused on food, beverage, and consumer staples, but they pursue exposure through different indexes and screening methodologies.
- FXG holds roughly 41 stocks with broader sector reach, including healthcare distributors such as CAH and MCK, while PBJ is a more concentrated, non-diversified fund of about 30 to 32 food-and-beverage names.
- Both funds carry an expense ratio near 0.63%, placing them at the higher end relative to plain-vanilla consumer staples ETFs.
- PBJ is a purer play on packaged foods, beverages, and food distribution, whereas FXG blends staples with healthcare and a multi-cap growth-and-value factor tilt.
- On diversification, defensive breadth, and balanced factor construction, Tickeron's AI Verdict favors FXG of the two.
Why These Two ETFs Often Appear Together
Investors looking for defensive, consumer-oriented equity exposure frequently compare the First Trust Consumer Staples AlphaDEX Fund (FXG) and the Invesco Food & Beverage ETF (PBJ). Although both sit in the broader consumer staples universe, they are not interchangeable. FXG applies First Trust's AlphaDEX multi-factor screening across a wider staples segment, while PBJ focuses strictly on U.S. food and beverage companies selected through a quantitative momentum-and-quality model. I find it useful to examine their differences in sector exposure, concentration, and index methodology before deciding on relative positioning.
First Trust Consumer Staples AlphaDEX Fund (FXG) at a Glance
FXG seeks to track the StrataQuant Consumer Staples AlphaDEX Index, an enhanced index that selects stocks from the Russell 1000 universe using the AlphaDEX methodology. The approach ranks candidates on growth factors such as recent price appreciation and sales growth, alongside value factors including book value to price and cash flow to price. Selected names are divided into tiers and weighted in a modified equal-dollar fashion, with quarterly reconstitution and rebalancing. The fund holds approximately 41 positions. Representative top holdings include FRPT, CAH, PPC, POST, INGR, MKC, STZ, and MCK. Consumer staples account for the majority of assets, but the fund also carries a meaningful healthcare allocation through distributors like Cardinal Health and McKesson, plus smaller consumer cyclical and industrial stakes. FXG carries an expense ratio of approximately 0.63% and launched in May 2007. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Invesco Food & Beverage ETF (PBJ) at a Glance
PBJ seeks to track the Dynamic Food & Beverage Intellidex Index, a quantitative, rules-based benchmark composed of roughly 30 U.S. food and beverage companies. The Intellidex methodology evaluates constituents on factors including fundamental growth, valuation, investment timeliness, and risk, then applies a tiered weighting scheme. The index is rebalanced quarterly, and the fund is classified as non-diversified. The portfolio holds approximately 30 to 32 securities. Leading positions include KR, KDP, ADM, KO, SYY, CTVA, SBUX, and MNST. Subsector exposure spans packaged foods and meats, soft drinks and non-alcoholic beverages, food distributors, food retail, and agricultural products. PBJ carries a net expense ratio of approximately 0.63% and has operated since June 2005.
Industry and Thematic Context
Both ETFs operate within the consumer staples complex, a segment investors traditionally turn to for steadier earnings, pricing power, and dividend support during periods of macroeconomic uncertainty. Recent market cycles have been shaped by persistent food-price inflation, shifting grocery and restaurant demand, and the rise of weight-loss medications that have pressured volume expectations for some packaged-food and beverage producers. Consolidation activity and supply-chain normalization have also influenced earnings across processors, distributors, and retailers. Interest-rate expectations matter as well: staples typically act as a defensive equity sleeve, but their relative appeal can fade when risk appetite returns to growth-oriented sectors. Within this environment, the broader, healthcare-adjacent composition of FXG provides a somewhat different risk profile than PBJ's purer food-and-beverage tilt.
Performance and Positioning Comparison
Over recent weeks and months, PBJ has displayed firmer relative momentum, supported by strength across beverage and food-distribution names, while FXG has been more range-bound as its healthcare and protein-related holdings experienced uneven earnings cycles. PBJ's concentrated exposure can amplify both gains and drawdowns when food and beverage sentiment shifts, whereas FXG's wider roster and healthcare sleeve tend to smooth single-stock and single-subsector volatility. From a cost standpoint the two funds are essentially identical, so differences in fund performance stem primarily from index construction and sector mix rather than fees. FXG's growth-and-value AlphaDEX tilt and its inclusion of healthcare distributors provide defensive diversification, while PBJ offers cleaner thematic access to the food value chain.
Using Tickeron AI Tools for This Comparison
When comparing ETFs like these, I often turn to Tickeron’s AI Screener to quickly filter holdings by industry, factor exposure, and recent performance patterns. It helps surface how the broader healthcare tilt in one fund stacks up against the concentrated food-and-beverage focus in the other, giving a clearer view of diversification differences without manual spreadsheet work. This kind of targeted scan has become a regular part of my process for validating relative positioning across market cycles.
Tickeron AI Verdict
Weighing structural strength, cost efficiency, diversification profile, and risk exposure, Tickeron's AI would currently favor FXG between the two funds. Although PBJ has shown stronger near-term trend consistency and offers purer food-and-beverage exposure, FXG's broader roster of roughly 41 holdings, its added healthcare-distribution sleeve, and its balanced growth-and-value factor methodology provide a more diversified and defensively resilient profile at a nearly identical cost. This broader, less concentrated construction may offer more consistent relative positioning across shifting market cycles, making FXG the more robust probabilistic choice of the pair.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
FXG in downward trend: price dove below 50-day moving average on October 26, 2026
FXG moved below its 50-day moving average on October 26, 2026 date and that indicates a change from an upward trend to a downward trend. In 39 of 50 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 78%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 28, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXG as a result. In 69 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 72%.
The 50-day moving average for FXG moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
FXG broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FXG's RSI Indicator exited the oversold zone, 20 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for FXG just turned positive on October 06, 2026. Looking at past instances where FXG's MACD turned positive, the stock continued to rise in 35 of 47 cases over the following month. The odds of a continued upward trend are 74%.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.
Following a +1.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 261 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 181 of 273 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Category ConsumerStaples
Advertisement